MENU
Clinical Presentation and Complications of Patients after Exposure to Substances Labeled “Bath Salts”
Description: This retrospective multicenter descriptive study will define the clinical presentation and medical complications of patients who present to the hospital after bath salt use.
PI/Contact: Dan Rusyniak
Email: drusynia@iupui.edu
Status: Approved 2011 - Inactive
Deliverables: J Med Toxicol 2015 June 11(2):185-94
CounterAct
Description: Use the ToxIC Registry to identify translational mechanism to collect human data on individuals exposed to high doses of threat agents of interest to the CounterACT program.
PI/Contact: Ben Hatten
Email: Benjamin.Hatten@ucdenver.edu
Status: Approved 2014 - Active
Deliverables: Abstract 2015 ACMT ASM
Post Stroke Overdose as Self Harm in Emergency Department Patients
Description: Multiple site study to identify the risk factors of overdose in patients within 1 year after stroke
PI/Contact: Michael Policastro
Email: toxicmd013@gmail.com
Status: Approved 2011 - Inactive
Deliverables: None
Quetiapine and QRS Study
Description: To retrospectively review clinical data in cases of quetiapine poisonings reported through the ToxIC registry to examine whether quetiapine poisoning results in a prolonged QRS duration
PI/Contact: Jason Oost
Email: oostj@ohsu.edu
Status: Approved 2013 - Active
Deliverables: None
Synthetic THC Study
Description: The purpose of this study is to produce a descriptive series of patient that experience seizures following synthetic THC use.
PI/Contact: Blake Froberg
Email: bfroberg@iupui.edu
Status: Approved 2012 - Inactive
Deliverables: None
What Medications Induce Serotonin Syndrome?
Description: We seek to determine a list of the medications that are truly responsible for serotonin toxicity as defined by a medical toxicologist using current criteria
PI/Contact: Rob Hendrickson
Email: hendriro@ohsu.edu
Status: Approved 2011 - Active
Deliverables: Abstract 2015 ACMT ASM
ToxIC Cool (Therapeutic Hypothermia)
Description: This prospective study intends to characterize the use of therapeutic hypothermia as a therapeutic modality following toxin-induced cardiac arrest
PI/Contact: Russ Kerns
Email: rkerns@carolinas.org
Status: Approved 2013 - Active
Deliverables: None
